Kiener Peter A 4
4 · LAVA Therapeutics NV · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Kiener Peter A
Director
Transactions
- Award
Common Shares (Right to Buy)
2025-02-13+33,390→ 33,390 totalExercise: $0.93Exp: 2035-02-12→ Common Shares (33,390 underlying)
Footnotes (1)
- [F1]100% of the shares underlying the option will vest on February 13, 2026, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on such vesting date.